原发性肝癌患者用血清、血浆标本测定循环VEGF浓度的差别(3)
[3] Kaseb AO，Hanbali A，Cotant M，et al.Vascular endothelial growth factor in the management of hepatocellular carcinoma： a review of literature[J].Cancer，2009，115：4895-4906.
[4] Llovet JM PC，Lathia CD， Shan M，et al.Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma[J].Clin Cancer Res，2012，18：2290-2300.
[5] Hsieh MY，Lin ZY，Chuang WL.Serial serum VEGF-A， angiopoietin-2， and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization[J].Kaohsiung J Med Sci，2011，27：314-322.
[6] Tamesa T，Iizuka N，Mori N，et al.High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma[J].Hepatogastroenterology，2009，56：1122-1126.
[7] Schoenleber SJ，Kurtz DM，Talwalkar JA，et al.Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma： systematic review and meta-analysis[J].Br J Cancer，2009，100：1385-1392.
(收稿日期：2012-09-04), 百拇医药(程洪涛 郭晨阳 黎海亮 肖金成 胡鸿涛 郑琳 宗登伟 余朴)
[4] Llovet JM PC，Lathia CD， Shan M，et al.Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma[J].Clin Cancer Res，2012，18：2290-2300.
[5] Hsieh MY，Lin ZY，Chuang WL.Serial serum VEGF-A， angiopoietin-2， and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization[J].Kaohsiung J Med Sci，2011，27：314-322.
[6] Tamesa T，Iizuka N，Mori N，et al.High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma[J].Hepatogastroenterology，2009，56：1122-1126.
[7] Schoenleber SJ，Kurtz DM，Talwalkar JA，et al.Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma： systematic review and meta-analysis[J].Br J Cancer，2009，100：1385-1392.
(收稿日期：2012-09-04), 百拇医药(程洪涛 郭晨阳 黎海亮 肖金成 胡鸿涛 郑琳 宗登伟 余朴)